The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Liposomal irinotecan plus fluorouracil/leucovorin versus FOLFIRINOX as the second-line chemotherapy for patients with metastatic pancreatic cancer: Multicenter study of the Korean Cancer Study Group (KCSG).
 
Hongjae Chon
Consulting or Advisory Role - AstraZeneca; Bayer; Celgene; Eisai; Menarini; MSD; Ono Pharmaceutical; Sanofi; SERVIER; Sillajen
Speakers' Bureau - Celgene; Eisai; Ipsen; Menarini; Sanofi; SERVIER
Research Funding - Sillajen; syntekabio
 
Hyung Soon Park
No Relationships to Disclose
 
Beodeul Kang
No Relationships to Disclose
 
Hyeon-Su Im
No Relationships to Disclose
 
Choong-kun Lee
No Relationships to Disclose
 
Ilhwan Kim
No Relationships to Disclose
 
Myoung Joo Kang
No Relationships to Disclose
 
Jun-Eul Hwang
No Relationships to Disclose
 
Woo Kyun Bae
No Relationships to Disclose
 
Jaekyung Cheon
No Relationships to Disclose
 
Jung Yong Hong
Research Funding - AstraZeneca
 
Jung Hun Kang
No Relationships to Disclose
 
Jung Hoon Kim
No Relationships to Disclose
 
Sung Hee Lim
No Relationships to Disclose
 
Jin Won Kim
No Relationships to Disclose
 
Ji-Won Kim
No Relationships to Disclose
 
Changhoon Yoo
Stock and Other Ownership Interests - Oncocross
Honoraria - Bayer; Ipsen; SERVIER
Consulting or Advisory Role - LSK BioPharma
Speakers' Bureau - Bayer; Celgene; Eisai; Ipsen; Merck Sharp & Dohme
Research Funding - AstraZeneca; Bayer; CKD pharm; SERVIER
 
Hye Jin Choi
No Relationships to Disclose
 
Joon Oh Park
Consulting or Advisory Role - AstraZeneca; Celgene; Merck Serono; Sanofi; SERVIER; Shire
Speakers' Bureau - Celgene
Research Funding - Celgene